Dr. Min Deng, MD

Dr. Deng practices at MedStar Washington Hospital Center in Washington, District of Columbia, part of MedStar Health.

Dr. Deng's NPI, 1225316193, was assigned on July 26, 2011. Dr. Deng graduated from Cleveland Medical College, Homeopathic in 2011. Dr. Deng holds Maryland license D0086823.

Dr. Deng's primary practice is MedStar Washington Hospital Center, at 110 Irving Street NW, Washington, DC 20010 in The District County. The practice phone is (202) 877-7000.

Dr. Deng's primary practice is MedStar Washington Hospital Center in Washington, District of Columbia, part of MedStar Health. Dr. Deng is also affiliated with MedStar Georgetown University Hospital. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Deng to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Deng practices, 4 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Deng's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Deng is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Deng's licenses on file in 6 states: Maryland, District of Columbia, West Virginia, New Jersey, Illinois and Massachusetts.

CMS data shows 1,396 Medicare services from Dr. Deng across 20 procedure codes in 2024, for 308 Medicare patients. Medicare paid $215,096 for them. Every service was in an office.

CMS counts 308 Medicare patients who saw Dr. Deng in 2024. The largest group is 75 to 84, with 139 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Deng's median patient age at 59, with 46% women.

In 2024, Dr. Deng wrote 104 Medicare Part D claims for 61 patients. 96% of them were for generic drugs. CMS names the drug for 43 of them, across 2 drugs with 11 or more claims each, at $1,322 in total drug cost. In 2023, CMS named 22 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Deng for performance year 2024, reported as part of a group. Dr. Deng accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 75 procedures of melanoma (skin cancer) excision by Dr. Deng, more than 90% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Deng, published from 2017 to 2024. 2023 was the busiest year, with 2. The most frequent topics are Skin Neoplasms, Carcinoma, Basal Cell and Mohs Surgery. Dr. Deng has published most often in Dermatol Surg. Dr. Deng's most frequent co-authors are Mark Biro, MD, Amanda Fleming Marsch, MD and Kristen L. Russomanno, MD.

CMS Open Payments shows 7 general payments to Dr. Deng from 2 drug and device companies from 2017 to 2024. Device or supply loans make up the largest share, 96% of the total. Integra LifeSciences Corporation paid the most, $1,441.

Dr. Deng graduated from Cleveland Medical College, Homeopathic in 2011.

Dr. Deng is in network with 19 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.